🚀 The 1st EORTC Summit in Clinical Cancer Research is coming!
AI, innovative methodologies, QOL, patient‑centricity, policy & more — all in one place.
📅 Save the date & help spread the word!
👉 www.eortc.org/summit
#EORTCSummit
👏 Proud to have our Scientific Director ,Saskia Litière, representing EORTC today at #ECR2026, contributing to the session on real‑world imaging biomarkers.
Great discussions on how imaging is evolving in clinical research and practice.
#EORTC #MedicalImaging #CancerResearch
🚀 New @eortc.org #QualityofLife Group review by Niclas Hubel et al. on the mode of assessment of questionnaires in cancer clinical trials: current practice & gaps in how questionnaires are assessed and need for better reporting.
🔗 doi.org/10.1007/s111...
#GivingVoice2Patients @msztankay.bsky.social
🎗️Tomorrow is #RareDiseaseDay.
Rare cancers represent 1 in 5 diagnoses and 1 in 3 cancer deaths.
Through its Rare Cancers Task Force, SPECTA & clinical trials, EORTC is advancing research and expanding treatment options for rare & ultra-rare cancers.
🔗 www.eortc.org/blog/2026/02...
📢 PEACE‑3 final results: adding radium‑223 to enzalutamide reduces risk of death by 24% in men with #mCRPC and bone metastases.
Results presented at ASCO @ascocancer.bsky.social #GU26 and published in Annals of Oncology.
🔗 Full press release: www.eortc.org/blog/2026/02...
#CancerResearch #PEACE3
EORTC has opened the first site for the #RENALUT study, launching a Phase II evaluation of [177Lu]Lu‑PSMA‑617 in metastatic clear cell renal cell carcinoma after progression on prior treatments. More sites across Europe will follow.
🔗Read more: www.eortc.org/blog/2026/02...
#ccRCC #CancerResearch
📣 Today at the German Cancer Congress, @eortc.org #QualityofLife Group highlights 3 important PRO projects: K. Taylor on #HNC survivorship; T. Nordhausen on TCIs for EORTC lung cancer module & PRO implementation in routine care.
www.deutscher-krebskongress.de
#DKK2026 @krebsgesellschaft.bsky.social
Today, EORTC CEO Denis Lacombe met with EU Health Commissioner Olivér Várhelyi to discuss the importance of independent clinical cancer research and the need for policies that support treatment optimisation and sustainable, patient‑centred cancer care in Europe.
#ClinicalTrials @ec.europa.eu
Over the past weeks, we shared stories from patients, advocates & researchers shaped by academic cancer research.
Thank you for following this journey. Together we can advance research and improve survival & quality of life.
Get involved 👉 www.eortc.org/impact
#WorldCancerDay #EORTCimpact
👏 Pleased to see the 2025 American Thyroid Association Guidelines emphasising the importance of validated #QualityofLife (QoL) measures and referring to the EORTC QLQ-THY34.
Disease-specific, validated tools are key to better understanding patients’ lived experience and QoL in #ThyroidCancer care. 👇
Happy International Day of Women & Girls in Science!
At EORTC, we celebrate the women advancing cancer research. 💡
Prof Piccart helped lead MINDACT, transforming breast cancer care and reducing unnecessary chemotherapy.
Find out more: www.eortc.org/impact/
#EORTCimpact
👉 In case you missed it, we’ve created a new webpage dedicated to EORTC’s impact over the last 60 years.
Discover more: www.eortc.org/impact
#WorldCancerDay #ClinicalTrials #EORTCimpact #CancerResearch #LeavingNoCancerPatientBehind
📢 Registrations are now open!
💻 Clinical Trial Statistics for Non-Statisticians course introduces the statistical methods used in the design, conduct and analysis of cancer clinical trials.
📅 Dates: 9-12 June 2026
👉 Register now: https://www.eortc.org/event/stats2026/
🎗️This World Cancer Day, we’re proud to share how the EORTC-led MINDACT study helped change breast cancer care worldwide.
Hear from patient Betty & Prof Piccart.
🔗 www.eortc.org/blog/2026/02...
A big thank you to everyone involved in this study!
#WorldCancerDay #EORTCimpact
🎓 ESOI–EORTC Workshop 2026
Interactive lectures and hands on workshops on imaging based tumour response assessment.
Designed for practising radiologists and radiology residents, with real life cancer cases from routine care and clinical trials.
🔗 https://www.esoi-society.org/esoi-eortc-2026/
🎗️Tomorrow is World Cancer Day.
We’ll be sharing Betty’s story, a patient whose experience with the MINDACT study shows how clinical cancer research can change lives.
🎬 Don’t miss it!
#WorldCancerDay #LeavingNoCancerPatientBehind #EORTCimpact #ClinicalTrials
Practice-changing research means results that directly transform patient care.
This World Cancer Day, EORTC will highlight MINDACT, a study that has changed the standard of care for breast cancer.
📅 Stay tuned!
#WorldCancerDay #ClinicalTrials #EORTCimpact #CancerResearch #CancerSurvivor
At the #BHPA Symposium in Bruges, Enrico Clementel presented E²‑RADIatE, the largest international programme collecting real‑world data to answer radiotherapy‑specific questions, including insights from OligoCare, ReCare and SPRINT.
👏 Congratulations on the presentation.
#Radiotherapy #BHPA2026
Why does funding for clinical research matter?
Because #ClinicalTrials depend on sustained investment to advance cancer treatment and provide better outcomes for patients.
👉 Like and reshare this message to highlight why cancer research matters.
#WorldCancerDay #EORTCimpact #CancerResearch
👏 Recently published in Pediatric Blood & Cancer: SIOP abstract by Chiara Vetrano about @eortc.org #QualityofLife Group systematic review mapping key HRQOL aspects for children with cancer under 8 years to refine PRO assessment in this population.
🔗 doi.org/10.1002/pbc....
#GivingVoice2Patients
📅 Save the date!
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
Why do academic #ClinicalTrials matter?
Because they show which treatments truly benefit patients.
Roger, an EORTC trial participant, shares why independent, non‑commercial cancer research is essential.
👉 Like & reshare to spread the word.
#WorldCancerDay #EORTCimpact#LeavingNoCancerPatientBehind
👏 Findings of a new international study by Lisa Wintner et al. in @thelancetoncol.bsky.social highlight the importance of integrating the patient’s voice into routine clinical evaluations and cancer research
👉 Read more: www.eortc.org/blog/2026/01...
#CancerResearch #QualityofLife @qol.eortc.org
📢 A couple of days left to apply to #MCCRWorkshop!
Have you submitted your application?
⏳ Deadline: 30 January 2026
📅 13–18 June 2026
👉 Submit your application here: https://event.eortc.org/mccr2026/application-submission/
#ClinicalTrialDesign #ClinicalResearch
📢 New findings in @JAMANetworkOpen.
Using data from five randomized trials, potent ALDH1A1‑activating PPIs were linked to reduced survival in patients with newly diagnosed glioblastoma. Other antacids showed no such effect.
🔗 www.eortc.org/publications/
#ClinicalResearch
📚 A week that makes a real difference.
Step back, refine your clinical trial protocol, receive continuous expert feedback and build lasting scientific connections.
📅 13–18 June 2026
⏳ Applications close 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
🚀 Milestones achieved for VIGOR (EORTC‑2427‑BTG)!
The first site is activated and the first patient has already been randomised in this Phase III study evaluating vorasidenib for IDH‑mutant astrocytoma.
A strong start for this international effort.
🔗 www.eortc.org/blog/2026/01...
Cancer clinical trials turn discoveries into better treatments. EORTC leads international trials, studying not just if treatments work, but how they improve patients’ quality of life.
👉 Like & reshare to raise awareness. #WorldCancerDay #ClinicalTrials #EORTCimpact
🎓Tomorrow is International Day of Education, a moment to celebrate the EORTC Early Career Investigator (ECI) programme, which empowers young doctors to drive #CancerResearch forward.
Meet Ioannis, Jens & Antonella from our ECI community.
Join us: https://www.eortc.org/early-career/
